Document:

EX-10.11

 Exhibit 10.11 

 
 

 
 [Date] 

Personal and Confidential 
 Advanced Merger
Partners, Inc. 
 c/o Saddle Point Management, L.P. 
 555 West
57th Street, Suite 1326 
 New York, NY 10019 
 Attn: Roy J.
Katzovicz, Chief Executive Officer 
 Dear Ladies and Gentlemen: 

This letter agreement (this “Agreement”) confirms the understanding and agreement between Advanced Merger Partners, Inc. (the
“Company”) and Houlihan Lokey Capital, Inc. (“Houlihan Lokey”) as follows: 
 1. Engagement; Services; Term.
We understand that the Company is contemplating an initial public offering of units, each of which is comprised of one share of Class A common stock and a certain fraction of one redeemable warrant (such offering, the
“Transaction”). The Company hereby retains Houlihan Lokey as its financial advisor to provide certain limited financial consulting services in connection with the Transaction. Houlihan Lokey’s services will consist of, if appropriate
and if requested by the Company, (i) reviewing the deal structure and terms and providing related structuring advice in connection with the Transaction, and (ii) providing such other financial consulting services as may be agreed upon by
Houlihan Lokey and the Company consistent with FINRA Rule 5110. 
 Notwithstanding anything to the contrary contained herein, the parties
acknowledge that Houlihan Lokey has not been retained hereunder to engage in, and will not receive any compensation under this Agreement or otherwise for, (i) identifying or introducing to the Company any prospective investors or other
participants in the Transaction, (ii) engaging in any distribution or solicitation activities with respect to any offering or otherwise participating (as defined under FINRA Rule 5110(j)(16)) in any offering, or (iv) providing any other
services that an independent financial advisor (as defined under FINRA Rule 5110(j)(9)) would not be permitted to provide. The Company further acknowledges and agrees that Houlihan Lokey is not acting as an underwriter of any units or other
securities of the Company and shall have no responsibility or obligation to underwrite or purchase any such units or other securities. 

This Agreement will commence as of the date of this Agreement and will continue thereafter (and not terminate or expire) until
terminated by either party upon five days’ prior written notice of termination to the other party; provided that this Agreement shall automatically terminate upon consummation of the Transaction. No expiration or termination of this Agreement
shall affect (a) the indemnification, reimbursement, contribution and other obligations and provisions set forth on Schedule A attached hereto, (b) the confidentiality provisions set forth herein, (c) Sections 3-5 hereof, and (d) Houlihan Lokey’s right to receive, and the Company’s obligation to pay, any and all fees and expenses due, all as more fully set forth in this Agreement. 

245 Park Avenue, 20th Floor ● New York, New York 10167 ● tel.212.497.4100 ●
fax.212.661.3070 ● www.HL.com 
 Broker/dealer services through Houlihan Lokey Capital, Inc. 

			
	Advanced Merger Partners, Inc.	  	 -
 2
 -

  

 2. Fees and Expenses. Upon the closing of the Transaction, the
Company shall pay Houlihan Lokey a non-refundable cash fee in an amount equal to 20% of the underwriting compensation payable to the underwriter(s) of the Transaction (including, without limitation, any
underwriting compensation due in connection with the over-allotment option if and when exercised by the underwriter(s)). 
 Houlihan Lokey
hereby irrevocably waives any and all right, title, interest, causes of action and claims of any kind as a result of, or arising out of, this Agreement (each, a “Claim”) in or to, and any and all right to seek payment of any amounts
due to it out of, the trust account established for the benefit of the public stockholders of the Company and into which substantially all of the proceeds of the Company’s initial public offering will be deposited (the “Trust
Account”), and hereby irrevocably waives any Claim it may have in the future, which Claim would reduce, encumber or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account, and further agrees not to
seek recourse, reimbursement, payment or satisfaction of any Claim against the Trust Account or any monies or other assets in the Trust Account for any reason whatsoever. 

3. Information. The Company will provide Houlihan Lokey with access to management and other representatives of the
Company, as reasonably requested by Houlihan Lokey. The Company will furnish Houlihan Lokey with such information as Houlihan Lokey may reasonably request for the purpose of carrying out its engagement hereunder, all of which will be, to the
Company’s best knowledge, accurate and complete at the time furnished. In addition, with respect to financial forecasts and projections that may be furnished to or discussed with Houlihan Lokey by the Company or any other entity, Houlihan Lokey
will be entitled to assume that such financial forecasts and projections have been or will be reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of the Company’s or such other
entity’s management, as the case may be, as to the matters covered thereby. The Company will promptly notify Houlihan Lokey in writing of any material inaccuracy or misstatement in, or material omission from, any information previously
delivered to, or discussed with, Houlihan Lokey, or any materials provided to any interested party. Houlihan Lokey shall rely, without independent verification, on the accuracy and completeness of all information that is publicly available and of
all information furnished by or on behalf of the Company or any other potential party to any Transaction or otherwise reviewed by, or discussed with, Houlihan Lokey. The Company understands and agrees that Houlihan Lokey will not be responsible for
the accuracy or completeness of such information, and shall not be liable for any inaccuracies or omissions therein. The Company acknowledges that Houlihan Lokey has no obligation to conduct any appraisal of any assets or liabilities of the Company
or any other party or to evaluate the solvency of any party under any applicable laws relating to bankruptcy, insolvency or similar matters. Houlihan Lokey’s role in reviewing any information is limited solely to performing such a review as it
shall deem necessary to support its own advice and analysis and shall not be on behalf of any other party. Any advice (whether written or oral) rendered by Houlihan Lokey pursuant to this Agreement is intended solely for the use of the Company in
evaluating a Transaction, and such advice may not be relied upon by any other person or entity or used for any other purpose. Any advice rendered by, or other materials prepared by, or any communication from, Houlihan Lokey may not be disclosed, in
whole or in part, to any third party, or summarized, quoted from, or otherwise referred to in any manner without the prior written consent of Houlihan Lokey. In addition, neither Houlihan Lokey nor the terms of this Agreement may otherwise be
referred to without our prior written consent. 

			
	Advanced Merger Partners, Inc.	  	 -
 3
 -

  

 4. Indemnification; Exculpation. The Company agrees to provide
indemnification, contribution and reimbursement to Houlihan Lokey and certain other parties in accordance with, and the Company further agrees to be bound by the other provisions set forth in, Schedule A attached hereto, which Schedule A is
incorporated herein and made a part hereof. 
 5. Miscellaneous. This Agreement shall be binding upon the parties
hereto and their respective successors, heirs and assigns and any successor, heir or assign of any substantial portion of such parties’ respective businesses and/or assets. Nothing in this Agreement, express or implied, is intended to confer or
does confer on any person or entity, other than the parties hereto, the HL Parties and each of their respective successors, heirs and assigns, any rights or remedies (directly or indirectly as a third party beneficiary or otherwise) under or by
reason of this Agreement or as a result of the services to be rendered by Houlihan Lokey hereunder. For purposes of this Agreement, the term “HL Parties” shall mean Houlihan Lokey and its affiliates, and their respective past, present and
future directors, officers, partners, members, employees, agents, representatives, advisors, subcontractors and controlling persons. 
 The
Company understands and acknowledges that Houlihan Lokey and its affiliates (collectively, the “Houlihan Lokey Group”) engage in providing investment banking, securities trading, financing, financial advisory, and consulting services and
other commercial and investment banking products and services to a wide range of institutions and individuals. In the ordinary course of business, the Houlihan Lokey Group and certain of its employees, as well as investment funds in which they may
have financial interests or with which they may co-invest, may acquire, hold or sell, long or short positions, or trade or otherwise effect transactions, in debt, equity, and other securities and financial
instruments (including bank loans and other obligations) of, or investments in, the Company or any other party that may be involved in the matters contemplated by this Agreement or have other relationships with such parties. With respect to any such
securities, financial instruments and/or investments, all rights in respect of such securities, financial instruments and investments, including any voting rights, will be exercised by the holder of the rights, in its sole discretion. In addition,
the Houlihan Lokey Group may in the past have had, and may currently or in the future have, financial advisory or other investment banking or consulting relationships with parties involved in the matters contemplated by this Agreement,
including parties that may have interests with respect to the Company, a Transaction or other parties involved in a Transaction, from which conflicting interests or duties may arise. Although the Houlihan Lokey Group in the course of such other
activities and relationships or otherwise may have acquired, or may in the future acquire, information about the Company, a Transaction or such other parties, or that otherwise may be of interest to the Company, the Houlihan Lokey Group shall have
no obligation to, and may not be contractually permitted to, disclose such information, or the fact that the Houlihan Lokey Group is in possession of such information, to the Company or to use such information on the Company’s behalf. 

The Company acknowledges that (i) an affiliate of Houlihan Lokey is an indirect member of the Company’s sponsor, and
(ii) certain officers of one or more of Houlihan Lokey or its affiliates are directors and/or officers of the Company (the “Houlihan Lokey Representatives”). The Company acknowledges that the duties of Houlihan Lokey as financial
advisor differ from those of the Houlihan Lokey Representatives. The Company (on its own behalf and, to the extent permitted by applicable law, on behalf of its security holders) knowingly and voluntarily waives any conflicts of interest which may
result from Houlihan Lokey’s multiple roles as, on the one hand, an advisor to the Company hereunder and as, on the other hand, an affiliate of an indirect member of the Company’s sponsor and of the Houlihan Lokey Representatives. In
addition, the Company acknowledges that no advice rendered by Houlihan Lokey hereunder shall be deemed a representation that its affiliate that is an indirect member of the Company’s sponsor or the Houlihan Lokey Representatives would support a
Transaction structured in accordance with such advice. 
 In order to enable Houlihan Lokey to bring relevant resources to bear on its
engagement hereunder from among its global affiliates, the Company agrees that Houlihan Lokey may share information obtained from the Company and other parties hereunder with other members of the Houlihan Lokey Group, and may perform the services
contemplated hereby in conjunction with such other members. 

			
	Advanced Merger Partners, Inc.	  	 -
 4
 -

  

 The parties understand that Houlihan Lokey is being engaged hereunder as an independent
contractor to provide the services described above solely to the Company, and that Houlihan Lokey is not acting as an agent or fiduciary of the Company, the security holders or creditors of the Company or any other person or entity in connection
with this engagement, and the Company agrees that it shall not make, and hereby waives, any claim based on an assertion of such an agency or fiduciary relationship. Any duties of Houlihan Lokey arising by reason of this Agreement or as a result of
the services to be rendered by Houlihan Lokey hereunder will be owed solely to the Company. 
 The invalidity or unenforceability of any
provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect pursuant to the terms hereof. 

The Company agrees that it will be solely responsible for ensuring that any Transaction complies with applicable law. The Company understands
that Houlihan Lokey is not undertaking to provide any legal, regulatory, accounting, insurance, tax or other similar professional advice. The Company acknowledges that Houlihan Lokey will not be distributing securities or acting as an agent with
respect to the placement of any securities for any party pursuant to this Agreement. 
 This Agreement is the complete and exclusive
statement of the entire understanding of the parties regarding the subject matter hereof, and supersedes all previous agreements or understandings regarding the same, whether written or oral. 

This Agreement may not be amended, and no portion hereof may be waived, except in a writing duly executed by the parties hereto. 

This Agreement has been reviewed by the signatories hereto and their counsel. There shall be no construction of any provision against Houlihan
Lokey because this Agreement was drafted by Houlihan Lokey, and the parties waive any statute or rule of law to such effect. 
 The Company
has all requisite power and authority to enter into this Agreement. This Agreement has been duly and validly authorized by all necessary action on the part of the Company and has been duly executed and delivered by the Company and constitutes a
legal, valid and binding agreement of the Company, enforceable in accordance with its terms. 
 This Agreement may be executed in any number
of counterparts, each of which will be deemed an original and all of which will constitute one and the same instrument. Such counterparts may be delivered by one party to the other by facsimile or other electronic transmission, and such counterparts
shall be valid for all purposes. 
 THIS AGREEMENT AND ALL DISPUTES ARISING OUT OF OR RELATED TO THIS AGREEMENT (WHETHER BASED UPON
CONTRACT, TORT OR OTHERWISE) SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAWS. EACH OF HOULIHAN LOKEY AND THE COMPANY (ON ITS OWN BEHALF AND, TO THE EXTENT
PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS EQUITY HOLDERS) IRREVOCABLY WAIVES ANY RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED UPON CONTRACT, TORT OR OTHERWISE) RELATED TO OR ARISING OUT OF THE ENGAGEMENT OF
HOULIHAN LOKEY PURSUANT TO, OR THE PERFORMANCE BY HOULIHAN LOKEY OF THE SERVICES CONTEMPLATED BY, THIS AGREEMENT. 

			
	Advanced Merger Partners, Inc.	  	 -
 5
 -

  

 REGARDLESS OF ANY PRESENT OR FUTURE DOMICILE OR PRINCIPAL PLACE OF BUSINESS OF THE PARTIES
HERETO, EACH PARTY HEREBY IRREVOCABLY CONSENTS AND AGREES THAT ANY CLAIMS OR DISPUTES BETWEEN OR AMONG THE PARTIES HERETO ARISING OUT OF OR RELATED TO THIS AGREEMENT (WHETHER BASED UPON CONTRACT, TORT OR OTHERWISE) SHALL BE BROUGHT AND MAINTAINED IN
ANY FEDERAL OR STATE COURT OF COMPETENT JURISDICTION SITTING IN THE COUNTY OF NEW YORK IN THE STATE OF NEW YORK OR IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, WHICH COURTS SHALL HAVE EXCLUSIVE JURISDICTION OVER THE
ADJUDICATION OF SUCH MATTERS, AND AGREES TO VENUE IN SUCH COURTS. EACH PARTY FURTHER IRREVOCABLY SUBMITS AND CONSENTS IN ADVANCE EXCLUSIVELY TO SUCH JURISDICTION AND VENUE IN ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURTS, AND HEREBY WAIVES IN ALL
RESPECTS ANY CLAIM OR OBJECTION WHICH IT MAY HAVE BASED UPON LACK OF PERSONAL JURISDICTION, IMPROPER VENUE OR FORUM NON CONVENIENS. THE COMPANY AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION, SUIT OR CLAIM BROUGHT IN ANY OF THE COURTS REFERRED TO
ABOVE SHALL BE CONCLUSIVE AND BINDING UPON IT AND MAY BE ENFORCED IN ANY OTHER COURTS HAVING JURISDICTION OVER IT BY SUIT UPON SUCH JUDGMENT. THE COMPANY IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN ALL SUCH DISPUTES BY THE MAILING OF COPIES OF
SUCH PROCESS TO THE COMPANY AT ITS ADDRESS SET FORTH ABOVE. 

			
	Advanced Merger Partners, Inc.	  	 -
 6
 -

  

 Please confirm that the foregoing terms are in accordance with your understanding by signing
and returning a copy of this Agreement. 
 Sincerely, 

HOULIHAN LOKEY CAPITAL, INC. 
  

			
	By:	 	  

		 	[Name]
		 	[Title]
	
	Accepted and agreed to as of the date first written above:
	
	ADVANCED MERGER PARTNERS, INC.
		
	By:	 	  

		 	Roy J. Katzovicz
		 	Chief Executive Officer

 SCHEDULE A 

This Schedule is attached to, and constitutes a material part of, that certain agreement (the “Agreement”) dated
[____________, 20__], between Advanced Merged Partners, Inc. (the “Company”) and Houlihan Lokey Capital, Inc. (“Houlihan Lokey”). Unless otherwise noted, all capitalized terms used herein shall have the
meanings set forth in the Agreement. 
 As a material part of the consideration for the agreement of Houlihan Lokey to furnish its services
under the Agreement, the Company agrees (i) to indemnify and hold harmless each HL Party, to the fullest extent lawful, from and against any and all losses, claims, damages or liabilities (or actions in respect thereof), joint or several,
arising out of or related to Houlihan Lokey’s engagement under, or any matter referred to in, the Agreement, and (ii) to reimburse each HL Party for all expenses (including, without limitation, the fees and expenses of counsel) as they are
incurred in connection with investigating, preparing, pursuing, defending, settling, compromising or otherwise becoming involved in any action, suit, dispute, inquiry, investigation or proceeding, pending or threatened, brought by or against any
person or entity (including, without limitation, any shareholder or derivative action or any claim to enforce the Agreement), arising out of or related to Houlihan Lokey’s engagement under, or any matter referred to in, the Agreement. However,
the Company shall not be liable under the foregoing indemnification provision for any loss, claim, damage or liability which arises out of any action or failure to act by such HL Party (other than an action or failure to act undertaken at the
request or with the consent of the Company) and is finally judicially determined by a court of competent jurisdiction to have resulted primarily from the willful misconduct or gross negligence of such HL Party. 

If for any reason the foregoing indemnification or reimbursement is unavailable to any HL Party or insufficient to fully indemnify any HL
Party or hold it harmless in respect of any losses, claims, damages, liabilities or expenses referred to in subsections (i) or (ii) of such indemnification or reimbursement provisions, then the Company shall contribute to the amount paid or
payable by such HL Party as a result of such losses, claims, damages, liabilities or expenses in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and Houlihan Lokey, on the other hand, in
connection with the matters contemplated by the Agreement. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law, then the Company shall contribute to such amount paid or payable by such HL
Party in such proportion as is appropriate to reflect not only such relative benefits, but also the relative fault of the Company (and its affiliates, and their respective directors, employees, agents and other advisors), on the one hand, and such
HL Party, on the other hand, in connection therewith, as well as any other relevant equitable considerations. Notwithstanding the foregoing, in no event shall the HL Parties be required to contribute an aggregate amount in excess of the amount of
fees actually received by Houlihan Lokey from the Company pursuant to the Agreement. Relative benefits received by the Company, on the one hand, and Houlihan Lokey, on the other hand, shall be deemed to be in the same proportion as (i) the
total value paid or received or contemplated to be paid or received by the Company, and its security holders, creditors, and other affiliates, as the case may be, pursuant to the transaction(s) (whether or not consummated) contemplated by the
engagement hereunder, bears to (ii) the fees received by Houlihan Lokey under the Agreement. The Company shall not settle, compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened action,
suit, dispute, inquiry, investigation or proceeding arising out of or related to Houlihan Lokey’s engagement under, or any matter referred to in, the Agreement (whether or not an HL Party is an actual or potential party thereto), or participate
in or otherwise facilitate any such settlement, compromise, consent or termination by or on behalf of any person or entity, unless such settlement, compromise, consent or termination contains a release of the HL Parties reasonably satisfactory in
form and substance to Houlihan Lokey. 

 The Company further agrees that neither Houlihan Lokey nor any other HL Party shall have any
liability (whether direct or indirect and regardless of the legal theory advanced) to the Company or any person or entity asserting claims on behalf of or in right of the Company arising out of or related to Houlihan Lokey’s engagement under,
or any matter referred to in, the Agreement, except for losses, claims, damages or liabilities incurred by the Company which arise out of any action or failure to act by such HL Party (other than an action or failure to act undertaken at the request
or with the consent of the Company) and are finally judicially determined by a court of competent jurisdiction to have resulted primarily from the willful misconduct or gross negligence of such HL Party. The indemnity, reimbursement, and other
obligations and agreements of the Company set forth in the Agreement (i) shall, for the avoidance of doubt, apply to any activities or actions arising out of or related to Houlihan Lokey’s engagement under, or any matter referred to in,
the Agreement, prior to the date hereof, and to any modifications of the Agreement, and (ii) shall be in addition to any obligation or liability which the Company may otherwise have to any HL Party. The Company agrees that Houlihan Lokey would
be irreparably injured by any breach of any such obligations or agreements, that money damages alone would not be an adequate remedy for any such breach and that, in the event of any such breach, Houlihan Lokey shall be entitled, in addition to any
other remedies, to injunctive relief and specific performance.Exhibit 42

		
			EXHIBIT 4.2
		

		
			DESCRIPTION OF THE REGISTRANT’S SECURITIES
		

		
			REGISTERED PURSUANT TO SECTION 12 OF THE
		

		
			SECURITIES EXCHANGE ACT OF 1934
		

		
			﻿
		

		
			As of December 31, 2020, Globus Medical, Inc. (the “Company”,  “our”, “us”, or “we”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): Class A common stock, par value $.001 per share. The Company’s Class A common stock is listed on the New York Stock Exchange under the trading symbol “GMED”.
		

		
			﻿
		

		
			DESCRIPTION OF COMMON STOCK
		

		
			﻿
		

		
			The following is a description of the rights of our Class A and Class B common stock and related provisions of the Company’s Amended and Restated Certificate of Incorporation (the “Certificate”), Amended and Restated Bylaws (the “Bylaws”), and applicable Delaware law. This description is qualified in its entirety by, and should be read in conjunction with, the Certificate, Bylaws, and applicable Delaware law.
		

		
			﻿
		

		
			Authorized Capital Stock
		

		
			﻿
		

		
			The Company’s authorized capital stock consists of 500,000,000 shares of Class A common stock and 275,000,000 shares of Class B common stock. The Company is authorized to issue up to 35,000,000 shares of preferred stock. As of December 31, 2020, the Company does not have any issued or outstanding shares of preferred stock.
		

		
			﻿
		

		
			Common Stock
		

		
			﻿
		

		
			Fully Paid and Nonassessable
		

		
			﻿
		

		
			All of the outstanding shares of the Company’s common stock are fully paid and nonassessable.
		

		
			﻿
		

		
			Voting Rights
		

		
			﻿
		

		
			Holders of our Class A and Class B common stock have identical voting rights, except that holders of our Class A common stock are entitled to one vote per share and holders of our Class B common stock are entitled to 10 votes per share. Holders of shares of our Class A and Class B common stock will vote together as a single class on all matters (including the election of directors) submitted to a vote of stockholders, unless otherwise required by law or the Certificate. Delaware law could require either our Class A common stock or our Class B common stock to vote separately as a single class in the following circumstances:
		

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			If we were to seek to amend the Certificate or increase or decrease the authorized number of shares of a class of stock, or to increase or decrease the par value of a class of stock, then that class would be required to vote separately to approve the proposed amendment; and

			
	
			
				 ·
			

			
	
			
			If we were to seek to amend the Certificate in a manner that altered or changed the powers, preferences or special rights of a class of stock in a manner that affected them adversely, then that class would be required to vote separately to approve the proposed amendment.

		
			﻿
		

		
			We have not provided for cumulative voting for the election of directors in the Certificate. Our Board of Directors (the “Board”) is divided into three classes, which are as nearly equal in number as possible, with each director elected at an annual stockholders’ meeting serving a three-year term and one class being elected at each year’s annual meeting of stockholders.
		

		
			﻿
		

		
			Dividend Rights
		

		
			﻿
		

		
			Subject to preferences that may apply to any shares of preferred stock outstanding at the time, if any, the holders of outstanding shares of Class A and Class B common stock are entitled to receive dividends out of funds legally available at the times and in the amounts that the Board may determine. Dividends may be paid in cash, in property, or in shares of the Company’s capital stock. If dividends are paid in shares of stock or rights to purchase shares of stock, the holders of Class A common stock will receive shares of Class A common stock or rights to purchase shares of Class A common stock and the holders of Class B common stock will receive shares of Class B common stock or rights to purchase shares of Class B common stock.
		

		
			﻿
		

		
			Right to Receive Liquidation Distributions
		

		
			﻿
		

		
			Upon the Company’s liquidation, dissolution, distribution of assets or winding-up, the assets legally available for distribution to stockholders would be distributable ratably among the holders of Class A and Class B common stock and any participating preferred stock outstanding at that time, if any, after payment of liquidation preferences, if any, on any outstanding shares of preferred stock and payment of other claims of creditors.
		

		

		

		 

 

		﻿
		

		
			No Preemptive or Similar Rights
		

		
			﻿
		

		
			Neither Class A nor Class B common stock is entitled to preemptive rights, and neither is subject to redemption. There are no sinking fund provisions applicable to the Company’s common stock.
		

		
			﻿
		

		
			Conversion
		

		
			﻿
		

		
			Our Class A common stock is not convertible into any other shares of our capital stock. Each share of our Class B common stock is convertible at any time at the option of the holder into one share of our Class A common stock. In addition, each share of our Class B common stock will convert automatically into one share of our Class A common stock upon any transfer, whether or not for value, except for permitted transfers. Class B common stockholders may transfer shares of Class B common stock in the following manner without having the shares of Class B common stock convert to Class A common stock:
		

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			the granting of a proxy to officers or directors of the Company whether or not at the request of the Board in connection with actions to be taken at an annual or special meeting of stockholders;

			
	
			
				 ·
			

			
	
			
			entering into a voting trust, agreement or arrangement (with or without granting a proxy) pursuant to which voting control is granted over such share to an officer or director of the Company that does not involve any payment of cash, securities, property or other consideration to the Class B stockholder other than the mutual promise to vote shares in a designated manner;

			
	
			
				 ·
			

			
	
			
			a transfer by a stockholder who is an individual upon such stockholder’s death pursuant to a will or the laws of descent and distribution;

			
	
			
				 ·
			

			
	
			
			any transfer of convertible securities;

			
	
			
				 ·
			

			
	
			
			any transfer to an affiliate; or

			
	
			
				 ·
			

			
	
			
			any transfer by an individual stockholder to, or for the benefit of, any spouse or any ancestor, descendant, sibling, or child of a sibling of such stockholder or his or her spouse, or any transfer by a stockholder to a trust, limited partnership or limited liability company for the benefit of such individual stockholder or any such family member, or any transfer by such a trust, partnership or limited liability company to any such stockholder or family member.

		
			﻿
		

		
			With respect to each holder of one or more shares of our Class B common stock, each of such holder’s shares of Class B common stock will automatically convert into one share of our Class A common stock if:
		

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			such holder’s shares of Class B common stock, together with the shares of Class B common stock then held by that holder’s affiliates, represents less than 5% of the aggregate number of all outstanding shares of our common stock.

		
			﻿
		

		
			Once converted into Class A common stock, Class B common stock cannot be reissued.
		

		
			﻿
		

		
			Anti-Takeover Provisions of the Certificate, Bylaws, and Delaware Law
		

		
			﻿
		

		
			The provisions of Delaware law, our dual class structure, the Certificate and Bylaws may have the effect of delaying, deferring or discouraging another person from acquiring control of our company.
		

		
			﻿
		

		
			Delaware Law
		

		
			﻿
		

		
			We are governed by the provisions of Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a public Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three years after the date of prescribed manner. A “business combination” includes mergers, asset sales or other transactions resulting in a financial benefit to the stockholder. An “interested stockholder” is a person who, together with affiliates and associates, owns, or within three years did own, 15% or more of the corporation’s outstanding voting stock. These provisions may have the effect of delaying, deferring or preventing a change in our control.
		

		
			﻿
		

		
			Amended and Restated Certificate of Incorporation and Amended and Restated Bylaw Provisions
		

		
			﻿
		

		
			The Certificate and Bylaws provide for a dual class structure and include a number of other provisions that could deter hostile takeovers or delay or prevent changes in control of our management team, including the following:
		

		
			﻿
		

		
			Dual Class Structure
		

		
			﻿
		

		
			As discussed above, our Class B common stock has 10  votes per share, while our Class A common stock has one vote per share. David C. Paul, a director and our current Executive Chairman, and his affiliates, in the aggregate, beneficially own 100% of our outstanding Class B common stock, representing approximately 74.7% of the total voting power of our outstanding capital stock. Because of our dual class structure, the holders of our Class B common stock will continue to be able to control all matters submitted to our stockholders for approval even if they own significantly less than 50% of the shares of our outstanding common stock. This 
		

		 

 

		concentrated control could discourage others from initiating any potential merger, takeover or other change of control transaction that other stockholders might view as beneficial. The Board is authorized, without stockholder approval, to issue additional authorized shares of our Class A and Class B common stock.
		

		
			﻿
		

		
			Board of Directors Vacancies
		

		
			﻿
		

		
			The Certificate and Bylaws authorize our board of directors or stockholders (at a duly convened meeting) to fill vacant directorships.
		

		
			﻿
		

		
			Classified Board
		

		
			﻿
		

		
			The Bylaws provide that the Board is classified into three classes of directors. This could delay a successful tender offeror from obtaining majority control of the Board, and the prospect of that delay might deter a potential offeror. In addition, stockholders are not permitted to cumulate their votes for the election of directors.
		

		
			﻿
		

		
			Stockholder Action; Special Meeting of Stockholders
		

		
			﻿
		

		
			The Bylaws provide that our stockholders may not take action by written consent, but may only take action at annual or special meetings of our stockholders. The Bylaws further provide that special meetings of our stockholders may be called only by a majority of our board of directors.
		

		
			﻿
		

		
			Advance Notice Requirements for Stockholder Proposals and Director Nominations
		

		
			﻿
		

		
			The Bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for election as directors at our annual meeting of stockholders. To be timely, a stockholder’s notice must be delivered to, or mailed and received at, our principal executive offices not more than 90 nor less than 50 days prior to the meeting with respect to an annual meeting of stockholders, and not later than 10 business days after public announcement of a special meeting. The Bylaws also specify certain requirements regarding the form and content of a stockholder’s notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders.
		

		
			﻿
		

		
			Preferred Stock
		

		
			﻿
		

		
			The Board has the authority, without further action by our stockholders, to issue up to 35,000,000 shares of undesignated preferred stock with rights and preferences, including voting, dividend, redemption, liquidation or preemptive rights, designated from time to time by the Board, which could be in preference or priority to the rights of holders of our Class A and Class B common stock. The Board may utilize such shares for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. Also, the existence of authorized but unissued shares of preferred stock would enable the Board to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or other means. If we issue such shares without stockholder approval and in violation of limitations imposed by the New York Stock Exchange or any stock exchange on which our stock may then be trading, our stock could be delisted.
		

		
			﻿
		

		
			Listing
		

		
			﻿
		

		
			The Company’s Class A common stock is listed on the New York Stock Exchange under the trading symbol “GMED”.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]